However, some tumors can evade the immune response by expressing the programmed cell death ligand PD-L1, which binds the PD-1 receptor on T-lymphocytes and disrupts cytotoxic activity of the latter, leading to higher tumor aggressiveness and progression (23, 25, 28). The gene discussed is CD274; the disease is neoplasm.